期刊文献+

间质性肺病合并肺癌的临床分析 被引量:2

Clinical analysis of interstitial lung disease associated with lung cancer
原文传递
导出
摘要 目的探讨间质性肺病合并肺癌患者的临床特点,以提高临床诊治水平。方法对8例经病理确诊的间质性肺病合并肺癌患者的临床表现、影像学、病理进行分析,治疗后随访。结果8例患者中男性6例,女性2例,6例有吸烟史,中位年龄64岁。主要临床症状为咯血、刺激性干咳、咳大量泡沫痰、胸闷气短加重。3例有免疫学指标阳性。影像学表现为沿胸膜下分布为主的细网格及蜂窝肺,伴肺内结节。间质性肺病类型为非特异性间质性肺炎及寻常型间质性肺炎;肺癌以腺癌为主。2例ANCA阳性的患者给予糖皮质激素治疗;5例患者行肺癌根治术,其中3例患者无法耐受术后化疗,2例患者术后给予辅助化疗,1例行单纯化疗后出现重度骨髓抑制死亡。另2例患者放弃进一步治疗,分别于确诊后8个月及10个月死亡。结论问质性肺炎合并肺癌起病隐匿,容易误诊、漏诊,临床应引起高度重视。 Objective To investigate the clinical features of interstitial lung disease associated with lung cancer. Methods The clinical manifestations, chest radiography, and pathology of eight interstitial lung disease associated with lung cancer patients were analyzed. All cases were followed up after treatment. Results The patients included six males and two females, six cases had history of smoking, three cases had positive immunological markers. The main clinical symptoms were hemoptysis, dry cough, frothy sputum,and shortness of breath. The pathological types of interstitial lung disease were usual interstitial pneumonia and nonspecific interstitial pneumonia. The pathological type of lung cancer was mainly adenocarcinoma. Five cases were treated with radical resection, three cases of them were unable to tolerate postoperative chemotherapy, two cases of them were given adjuvant chemotherapy. One case was died of severe bone marrow suppression after chemotherapy. The other two cases abandoned further treatment and died at eight months and ten months after diagnosis, respectively. Conclusions Interstitial lung disease associated with lung cancer is usually occult in onset and should be paid attention.
出处 《国际呼吸杂志》 2013年第24期1848-1851,共4页 International Journal of Respiration
关键词 间质性肺病 肺癌 临床特点 误诊 Interstitial lung disease Lung cancer Clincal manifestations Misdiagnosis
  • 相关文献

参考文献18

  • 1Le Jeune I,Gribbin J,West J. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in theUK[J].{H}Respiratory Medicine,2007.2534-2540.
  • 2American Thoracic Society. Idiopathic pulmonary fibrosis:diagnosis and treatment.International consensus statement.American Thoracic Society (ATS),and the European Respiratory Society (ERS)[J].{H}American Journal of Respiratory and Critical Care Medicine,2000.646-664.
  • 3American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS),and the European Respiratory Society (ERS) was adopted by the ATS board of directors,June 2001 and by the ERS Executive Committee,June 2001[J].AmJ RespirCrit CareMed,2002.277-304.
  • 4Tafti SF,Mokri B,Mohammadi F. Comparison of clinicoradiologic manifestation of nonspecific interstitial pneumonia and usual interstitial pneumonia/idiopathic pulmonary fibrosis:a report from NRITLD[J].Ann Thorac Med,2008.140-145.
  • 5易祥华.重视间质性肺疾病的病理学[J].中华病理学杂志,2006,35(7):386-388. 被引量:20
  • 6Maher TM,Wells AU,Laurent GJ. Idiopathic pulmonary fibrosis:multiple causes and multiple mechanisms[J].{H}European Respiratory Journal,2007.835-839.
  • 7Thannickal VJ,Horowitz JC. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis[J].{H}PROCEEDINGS OF THE AMERICAN THORACIC SOCIETY(PATS),2006.350-356.
  • 8K(o)nigshoff M. Lung cancer in pulmonary fibrosis:tales of epithelial cell plasticity[J].{H}RESPIRATION,2011.353-358.
  • 9K(o)nigshoff M,Kramer M,Balsara N. WNT1-inducible signaling protein 1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis[J].{H}Journal of Clinical Investigation,2009.772-787.
  • 10Willis BC,Liebler JM,Luby-Phelps K. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor beta1:potential role in idiopathic pulmonary fibrosis[J].{H}AMERICAN JOURNAL OF PATHOLOGY,2005.1321-1332.

二级参考文献25

  • 1陈岗,易祥华.呼吸系统疾病和肿瘤病理学的回顾与展望[J].中华病理学杂志,2005,34(8):490-493. 被引量:1
  • 2Bouros D, Hatzakis K, Labrakis H, et al. Association of malignancy with diseases causing interstitial pulmonary changes. Chest, 2002, 121: 1278 -1289.
  • 3American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med, 2000, 161: 646-664.
  • 4SharmaOP, Lamb C. Cancer in interstitial pulmonary fibrosis and sarcoidosis. Curr Opin Pulm Med, 2003, 9: 398- 401.
  • 5American Thoracic Society: European Respiratory Society. American Thoracic Society/European Respiratory Society International Muhidiseiplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board ofdirectors, June 2001 and by the ERS Executive Committee, June 2001. AmJRespirCrit CareMed, 2002, 165: 277-304.
  • 6Ma Y, Seneviratne C K, Koss M. Idiopathic pulmonary fibrosis and malignancy. Curr Opin Pulm Med, 2001, 7:278 -282.
  • 7Haddad R, Massaro D. Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer. Am J Med, 1968, 45: 211-219.
  • 8Park J, Kim D S, Shim T S, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J, 2001, 17: 1216-1219.
  • 9Qunn L, Takemura T, Ikushima S, et al. Hyperplastic epithelial loci in honeycomb lesions in idiopathic pulmonary fibrosis. Virchows Arch, 2002, 441: 271-278.
  • 10Chiyo M, Sekine Y, Iwata T, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg, 2003, 126: 1141-1146.

共引文献26

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部